Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health
Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health
Juvena’s Director of Discovery & Platform, Dr. Thach Mai presents “Mapping the therapeutic potential of secreted proteins through integrating AI and quantitative multi-omics technology” at the Element Biosciences Roadshow
CEO and co-Founder Dr. Hanadie Yousef recognized as In Vivo’s 2024 Rising Leaders, which includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.
One of In Vivo’s 2024 Rising Leaders, Dr. Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company’s lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.
Ashil Koranne presented a poster at the 2024 MDA Clinical & Scientific Conference highlighting Juvena Therapeutics’ promising preclinical development of JUV-161, a novel fusion protein for treating Myotonic Dystrophy Type 1.
CEO Dr. Yousef speaks about “The Science of Longevity: Stopping Aging at the Cellular Level to Prevent Disease and Improve Quality of Life” as an invited panelist for the 2023 Biotech Showcase.
